A novel method of predicting microRNA-disease associations based on microRNA, disease, gene and environment factor networks

Methods ◽  
2017 ◽  
Vol 124 ◽  
pp. 69-77 ◽  
Author(s):  
Wei Peng ◽  
Wei Lan ◽  
Jiancheng Zhong ◽  
Jianxin Wang ◽  
Yi Pan
Keyword(s):  
Disease Gene ◽  
Disease Associations ◽  
Novel Method ◽  
Environment Factor

scholarly journals MOSES: A New Approach to Integrate Interactome Topology and Functional Features for Disease Gene Prediction

Genes ◽  
2021 ◽  
Vol 12 (11) ◽  
pp. 1713
Author(s):  
Manuela Petti ◽  
Lorenzo Farina ◽  
Federico Francone ◽  
Stefano Lucidi ◽  
Amalia Macali ◽  
...  
Keyword(s):  
Network Topology ◽  
Disease Gene ◽  
Gene Prediction ◽  
Knowledge Bases ◽  
Biological Knowledge ◽  
Disease Genes ◽  
Human Interactome ◽  
Disease Gene Prediction ◽  
Disease Associations ◽  
Functional Features

Disease gene prediction is to date one of the main computational challenges of precision medicine. It is still uncertain if disease genes have unique functional properties that distinguish them from other non-disease genes or, from a network perspective, if they are located randomly in the interactome or show specific patterns in the network topology. In this study, we propose a new method for disease gene prediction based on the use of biological knowledge-bases (gene-disease associations, genes functional annotations, etc.) and interactome network topology. The proposed algorithm called MOSES is based on the definition of two somewhat opposing sets of genes both disease-specific from different perspectives: warm seeds (i.e., disease genes obtained from databases) and cold seeds (genes far from the disease genes on the interactome and not involved in their biological functions). The application of MOSES to a set of 40 diseases showed that the suggested putative disease genes are significantly enriched in their reference disease. Reassuringly, known and predicted disease genes together, tend to form a connected network module on the human interactome, mitigating the scattered distribution of disease genes which is probably due to both the paucity of disease-gene associations and the incompleteness of the interactome.

scholarly journals SNMDA: A novel method for predicting microRNA-disease associations based on sparse neighbourhood

2018 ◽  
Vol 22 (10) ◽  
pp. 5109-5120 ◽  
Author(s):  
Yu Qu ◽  
Huaxiang Zhang ◽  
Cheng Liang ◽  
Pingjian Ding ◽  
Jiawei Luo
Keyword(s):  
Disease Associations ◽  
Novel Method

scholarly journals Prediction of Disease-related microRNAs through Integrating Attributes of microRNA Nodes and Multiple Kinds of Connecting Edges

Molecules ◽  
2019 ◽  
Vol 24 (17) ◽  
pp. 3099 ◽  
Author(s):  
Xuan ◽  
Li ◽  
Zhang ◽  
Zhang ◽  
Song
Keyword(s):  
State Of The Art ◽  
Dimensional Space ◽  
Nonnegative Matrix ◽  
Superior Performance ◽  
Pancreatic Cancers ◽  
Node Attribute ◽  
Disease Associations ◽  
Node Attributes ◽  
Novel Method ◽  
Low Dimensional

Identifying disease-associated microRNAs (disease miRNAs) contributes to the understanding of disease pathogenesis. Most previous computational biology studies focused on multiple kinds of connecting edges of miRNAs and diseases, including miRNA–miRNA similarities, disease–disease similarities, and miRNA–disease associations. Few methods exploited the node attribute information related to miRNA family and cluster. The previous methods do not completely consider the sparsity of node attributes. Additionally, it is challenging to deeply integrate the node attributes of miRNAs and the similarities and associations related to miRNAs and diseases. In the present study, we propose a novel method, known as MDAPred, based on nonnegative matrix factorization to predict candidate disease miRNAs. MDAPred integrates the node attributes of miRNAs and the related similarities and associations of miRNAs and diseases. Since a miRNA is typically subordinate to a family or a cluster, the node attributes of miRNAs are sparse. Similarly, the data for miRNA and disease similarities are sparse. Projecting the miRNA and disease similarities and miRNA node attributes into a common low-dimensional space contributes to estimating miRNA-disease associations. Simultaneously, the possibility that a miRNA is associated with a disease depends on the miRNA’s neighbour information. Therefore, MDAPred deeply integrates projections of multiple kinds of connecting edges, projections of miRNAs node attributes, and neighbour information of miRNAs. The cross-validation results showed that MDAPred achieved superior performance compared to other state-of-the-art methods for predicting disease-miRNA associations. MDAPred can also retrieve more actual miRNA-disease associations at the top of prediction results, which is very important for biologists. Additionally, case studies of breast, lung, and pancreatic cancers further confirmed the ability of MDAPred to discover potential miRNA–disease associations.

scholarly journals MultiSourcDSim: an integrated approach for exploring disease similarity

2019 ◽  
Vol 19 (S6) ◽  
Author(s):  
Lei Deng ◽  
Danyi Ye ◽  
Junmin Zhao ◽  
Jingpu Zhang
Keyword(s):  
Integrated Approach ◽  
Data Sources ◽  
Related Data ◽  
The Past ◽  
Multiple Data ◽  
Disease Similarity ◽  
Disease Associations ◽  
Novel Method ◽  
Similarity Networks ◽  
Few Data

Abstract Background A collection of disease-associated data contributes to study the association between diseases. Discovering closely related diseases plays a crucial role in revealing their common pathogenic mechanisms. This might further imply treatment that can be appropriated from one disease to another. During the past decades, a number of approaches for calculating disease similarity have been developed. However, most of them are designed to take advantage of single or few data sources, which results in their low accuracy. Methods In this paper, we propose a novel method, called MultiSourcDSim, to calculate disease similarity by integrating multiple data sources, namely, gene-disease associations, GO biological process-disease associations and symptom-disease associations. Firstly, we establish three disease similarity networks according to the three disease-related data sources respectively. Secondly, the representation of each node is obtained by integrating the three small disease similarity networks. In the end, the learned representations are applied to calculate the similarity between diseases. Results Our approach shows the best performance compared to the other three popular methods. Besides, the similarity network built by MultiSourcDSim suggests that our method can also uncover the latent relationships between diseases. Conclusions MultiSourcDSim is an efficient approach to predict similarity between diseases.

A constrained probabilistic matrix decomposition method for predicting miRNA-disease associations

2020 ◽  
Vol 15 ◽  
Author(s):  
Xinguo Lu ◽  
Yan Gao ◽  
Zhenghao Zhu ◽  
Li Ding ◽  
Xinyu Wang ◽  
...  
Keyword(s):  
Matrix Decomposition ◽  
Disease Diagnosis ◽  
Similarity Network ◽  
Diagnosis And Prognosis ◽  
Non Coding Rna ◽  
Disease Similarity ◽  
Disease Associations ◽  
Novel Method ◽  
New Perspective ◽  
All Diseases

: MicroRNA is a type of non-coding RNA molecule whose length is about 22 nucleotides. The growing evidence shows that microRNA makes critical regulations in the development of complex diseases, such as cancers, cardiovascular diseases. Predicting potential microRNA-disease associations can provide a new perspective to achieve a better scheme of disease diagnosis and prognosis. However, there is a challenge to predict some potential essential microRNAs only with few known associations. To tackle this, we propose a novel method, named as constrained strategy for predicting microRNA-disease associations called CPMDA, in heterogeneous omics data. Here, we firstly construct disease similarity network and microRNA similarity network to preprocess the microRNAs with none available associations. Then, we apply probabilistic factorization to obtain two feature matrices of microRNA and disease. Meanwhile, we formulate a similarity feature matrix as constraints in the factorization process. Finally, we utilize obtained feature matrixes to identify potential associations for all diseases. The results indicate that CPMDA is superior over other methods in predicting potential microRNA-disease associations. Moreover, the evaluation show that CPMDA has a strong effect on microRNAs with few known associations. In case studies, CPMDA also demonstrated the effectiveness to infer unknown microRNAdisease associations for those novel diseases and microRNAs.

scholarly journals ID:2047 Drug respositioning by integrating known disease-gene and drug-target associations

2017 ◽  
Vol 4 (S) ◽  
pp. 76
Author(s):  
Duc-Hau Le ◽  
Duc-Hau Le
Keyword(s):  
Computational Methods ◽  
Drug Target ◽  
Disease Gene ◽  
State Of The Art ◽  
Drug Repositioning ◽  
Least Square ◽  
Data Sources ◽  
Chemical Structures ◽  
Drug Compounds ◽  
Disease Associations

Computational drug repositioning has been proven as a promising and efficient strategy for discovering new uses from existing drugs. To achieve this goal, a number of computational methods have been proposed, which are based on different data sources of drugs, diseases and different approaches. Depending on where the discovery of drug-disease relationships comes from, proposed computational methods can be categorized as either ‘drug-based’ or ‘disease-based’. The proposed methods are usually based on an assumption that similar drugs can be used for similar diseases to identify new indications of drugs. Therefore, similarity between drugs and between diseases is usually used as inputs. In addition, known drug-disease associations are also needed for the methods. It should be noted that these associations are still not well established due to many of marketed drugs have been withdrawn and this could affect to outcome of the methods. In this study, instead of using the known drug-disease associations, we based on known disease-gene and drug-target associations. In addition, similarity between drugs measured by chemical structures of drug compounds and similarity between diseases sharing phenotypes are used. Then, a semi-supervised learning model, Regularized Least Square (RLS), which can exploit these information effectively, is used to find new uses of drugs. Experiment results demonstrate that our method, namely RLSDR, outperforms several state-of-the-art existing methods in terms of area under the ROC curve (AUC). Novel indications for a number of drugs are identified and validated by evidences from different resources

scholarly journals Multi-Similarities Bilinear Matrix Factorization-Based Method for Predicting Human Microbe–Disease Associations

2021 ◽  
Vol 12 ◽  
Author(s):  
Xiaoyu Yang ◽  
Linai Kuang ◽  
Zhiping Chen ◽  
Lei Wang
Keyword(s):  
Matrix Factorization ◽  
Cross Validation ◽  
Cosine Similarity ◽  
Disease Associations ◽  
Novel Method ◽  
Inflammatory Bowel ◽  
Leave One Out ◽  
Association Matrix ◽  
Similarity Matrices

Accumulating studies have shown that microbes are closely related to human diseases. In this paper, a novel method called MSBMFHMDA was designed to predict potential microbe–disease associations by adopting multi-similarities bilinear matrix factorization. In MSBMFHMDA, a microbe multiple similarities matrix was constructed first based on the Gaussian interaction profile kernel similarity and cosine similarity for microbes. Then, we use the Gaussian interaction profile kernel similarity, cosine similarity, and symptom similarity for diseases to compose the disease multiple similarities matrix. Finally, we integrate these two similarity matrices and the microbe-disease association matrix into our model to predict potential associations. The results indicate that our method can achieve reliable AUCs of 0.9186 and 0.9043 ± 0.0048 in the framework of leave-one-out cross validation (LOOCV) and fivefold cross validation, respectively. What is more, experimental results indicated that there are 10, 10, and 8 out of the top 10 related microbes for asthma, inflammatory bowel disease, and type 2 diabetes mellitus, respectively, which were confirmed by experiments and literatures. Therefore, our model has favorable performance in predicting potential microbe–disease associations.

scholarly journals Diagnostic testing laboratories are valuable partners for disease gene discovery: 5-year experience with GeneMatcher

2021 ◽  
Author(s):  
Meghan Towne ◽  
Mari Rossi ◽  
Bess Wayburn ◽  
Jennifer Huang ◽  
Kelly Radtke ◽  
...  
Keyword(s):  
Disease Gene ◽  
Diagnostic Testing ◽  
Gene Discovery ◽  
Cost Savings ◽  
Testing Laboratories ◽  
Disease Gene Discovery ◽  
Disease Associations ◽  
Negative Report ◽  
Critical Resource ◽  
Unique Genes

Clinical and research laboratories extensively use exome sequencing due to its high diagnostic rates, cost savings, impact on clinical management, and efficacy for disease gene discovery. While the rates of disease gene discovery have steadily increased, only ~16% of genes in the genome have confirmed disease associations. Here we describe our diagnostic laboratory’s disease gene discovery and ongoing data-sharing efforts with GeneMatcher. In total, we submitted 246 candidates from 243 unique genes to GeneMatcher, of which 45.93% are now clinically characterized. Submissions with at least one case meeting our candidate genes reporting criteria were significantly more likely to be characterized as of October 2021 compared to genes with no candidates meeting our reporting criteria (p=0.025). We reported relevant findings related to these gene-disease associations for 480 probands. In 219 (45.63%) instances, these results were reclassifications after an initial candidate gene (uncertain) or negative report. Since 2013, we have co-authored 105 publications focused on delineating gene-disease associations. Diagnostic laboratories are pivotal for disease gene discovery efforts and can screen phenotypes based on genotype matches, contact clinicians of relevant cases, and issue proactive reclassification reports. GeneMatcher is a critical resource in these efforts.

Sign in / Sign up

Export Citation Format

Share Document